Carregant...
Liraglutide and obesity: a review of the data so far
The prevalence of obesity worldwide has nearly doubled since 1980 with current estimates of 2.1 billion in 2013. Overweight and obesity lead to numerous adverse conditions including type 2 diabetes, cardiovascular disease, stroke, and certain cancers. The worldwide spread of obesity and associated c...
Guardat en:
| Publicat a: | Drug Des Devel Ther |
|---|---|
| Autor principal: | |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Dove Medical Press
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4386791/ https://ncbi.nlm.nih.gov/pubmed/25848222 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S58459 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|